by Eric Christianson | Dec 25, 2019 | Clinical Pharmacy News and New Drug Updates
OTC Tamiflu may be a reality in the near future. Sanofi has purchased the over-the-counter rights for Tamiflu and is pursuing approval from the FDA. I do have some potential concerns with this medication becoming an over-the-counter option. For the pharmacology,...
by Eric Christianson | Oct 20, 2019 | Career Advice for Pharmacy Students, Residents and New Pharmacists, Clinical Pharmacy News and New Drug Updates
In an update from a previous post, the CPJE cheating scandal rolls on. Over 1,000 pharmacy students had their scores invalidated. This means that they have to make plans to retake the CPJE exam. In their most recent update on the CPJE cheating scandal, the California...
by Eric Christianson | Sep 25, 2019 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
The author has no conflicts of interest regarding oral semaglutide or any other diabetes medication. The GLP-1 agonists have been growing in popularity. The benefit of good A1C lowering effect coupled with the potential for weight loss are two of the main reasons why...
by Eric Christianson | Sep 11, 2019 | Cardiovascular Medication and Disease State Clinical Pearls, Clinical Pharmacy News and New Drug Updates, Medication and Disease State Clinical Pearls For Pharmacists
I’m a little bummed about my Minnesota Twins. Drug problems are everywhere and my team is not exempt. Apparently, hydrochlorothiazide is a drug of abuse in MLB’s drug testing policy. Mike Pineda, one of the Twins pitchers failed a drug test and was found...
by Eric Christianson | Jan 7, 2018 | Clinical Pharmacy News and New Drug Updates
I’m a few days late to the game here, but I wanted to share my 3 biggest clinical pharmacy changes from 2017. How did I select these? My opinion of course, and I’d love it if you would post one or two things below that you felt were important clinical...
by Eric Christianson | May 3, 2017 | Clinical Pharmacy News and New Drug Updates, Endocrine Medication and Disease State Clinical Pearls, Medication and Disease State Clinical Pearls For Pharmacists
So the FDA changed the labeling on metformin a while back and made it a little easier to use the drug in more patients who have poor kidney function. Whenever changes like this happen, I like to take a little time and digest the changes. From a recent Medscape...
